| payload |
{"artifact_id":"artf_thesis_c500e3040a {"artifact_id":"artf_thesis_c500e3040ad4b62e","evidence_event_ids":["evt_f139cd66a3c2","evt_4fc0bd746212","evt_b3fe7faacddb"],"kind":"opportunity_thesis","meta":{"confidence":0.4106,"lane":"monitor","morning_holdback":false,"rank_score":0.4106,"theme_keys":[],"urgency_reason":"not_urgent","urgent":false},"output_json":{"artifact_kind_detail":"research_thesis","catalysts":[],"confidence":0.4106,"decision_reason_codes":["research_thesis"],"headline":"Vir Biotechnology, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for May 26, 2026.","investigation_questions":["What changed vs prior known state is not provided in the signal; no prior filing/version details are included to identify deltas.","The filing\u2019s SEC accession number and the specific \u201cAmendment No.\u201d value are not shown (the text shows \u201c(Amendment No. )\u201d with no number).","The provided text does not include the substantive proxy content (e.g., what matters are being solicited/updated), because the extracted...","The signal is labeled \u201cdiscovery_sec_filing_delta,\u201d but no prior known state or comparison details are included in the provided text, so..."],"portfolio_fit":{"applied":false,"boost":0.0,"exit_risk_flagged":false,"hedge_suggested":null,"matched_holdings":[],"matched_watchlist":[],"stub_version":"v1","why_you":""},"related_tickers":["VIR"],"risk_level":"medium","theme_keys":[],"thesis":"Form DEF 14A \u00b7 Vir Biotechnology, Inc. \u00b7 Filed 20260416; The filing is a Schedule 14A proxy statement (DEF 14A) for Vir Biotechnology, Inc.; The notice states the 2026 Annual Meeting of Stockholders will be held on Tuesday, May 26, 2026 at 9:00 a.m. Pacific Time. \u2014 Signal convergence: Vir Biotechnology, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for May 26, 2026. [neutral]"},"ready_at":"2026-04-17T04:57:02.394043+00:00","status":"ready","summary":"Form DEF 14A \u00b7 Vir Biotechnology, Inc. \u00b7 Filed 20260416; The filing is a Schedule 14A proxy statement (DEF 14A) for Vir Biotechnology, Inc.; The notice states the 2026 Annual Meeting of Stockholders will be held on Tuesday, May 26, 2026 at 9:00 a.m. Pacific Time. \u2014 Signal convergence: Vir Biotechnology, Inc. filed a DEF 14A proxy statement for its 2026 Annua","title":"[THESIS] VIR \u2014 Vir Biotechnology, Inc. filed a DEF 14A proxy statement for its 2026 Annual Meeting of Stockholders, scheduled for May 26, 2026.","updated_at":"2026-04-17T04:57:02.394043+00:00"}... |